Figure 1
From: Treating psoriatic arthritis: how effective are TNF antagonists?
![Figure 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Far1016/MediaObjects/13075_2003_Article_1009_Fig1_HTML.jpg)
Percentage of etanercept- and placebo-treated patients demonstrating ACR20, ACR50, and ACR70 responses at 24 weeks. ACR, American College of Rheumatology. *P < 0.0001. †P = 0.009. Reproduced with permission from John Wiley & Sons, Inc. [27]. © 2001 American College of Rheumatology